Specific immunotherapy with high dose grass allergen tablets was safe in grass pollen induced asthma Source: Eur Respir J 2005; 26: Suppl. 49, 134s Year: 2005
Sublingual allergen specific immunotherapy in children with respiratory allergies – long lasting efficacy Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017
Estimation of prevalence of grass pollen sensitization among patients with seasonal allergic rhinitis in Armenia Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics Year: 2018
Safety of 5-grass pollen extract sublingual tablet in patients with grass pollen-induced allergic rhinoconjunctivitis and concomitant intermittent asthma: A pooled analysis Source: Annual Congress 2013 –Treatment of asthma Year: 2013
Prevalence of sensitization to grass pollen purified allergens in patients allergic to grass pollen Source: Eur Respir J 2002; 20: Suppl. 38, 507s Year: 2002
The specific methods of immunotherapy in treatment of the patients with allergic seasonal rhinitis Source: Eur Respir J 2002; 20: Suppl. 38, 507s Year: 2002
Sublingual immunotherapy is an established therapy for house dust mite sensitive allergic rhinitis and/or asthma Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007
Effects of oromucosal immunotherapy (SLIT) in children with respiratory allergy Source: Eur Respir J 2002; 20: Suppl. 38, 525s Year: 2002
The relation between pollen count and outbreak of seasonal allergic rhinitis for korean pollen allergy scale Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009
Clinical efficiency of sublingual and subcutaneous allergenspecific immunotherapy with household dust mite allergen in patients with persistent allergic rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 438s Year: 2006
Hypoallergenic high dose scit as add-on therapy in children with allergic asthma caused by house dust mites Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009
Efficacy of ruzam in the treatment of patients with perennial allergic rhinitis Source: Eur Respir J 2004; 24: Suppl. 48, 131s Year: 2004
Correlation between aeropollen concentration and symptoms of pollen allergy in children during the season Source: Eur Respir J 2005; 26: Suppl. 49, 401s Year: 2005
Relationship between ragweed pollen counts and delivery of anti allergic medication Source: Eur Respir J 2002; 20: Suppl. 38, 121s Year: 2002
Possible induction of oral allergy syndrome during specific immunoterapy in tree pollen sensitive patients - a preliminary study Source: Eur Respir J 2004; 24: Suppl. 48, 134s Year: 2004
Omalizumab is equally effective in persistent allergic oral corticosteroid-dependent asthma whether due to seasonal allergens or to perennial allergens Source: International Congress 2015 – Asthma and lung immunology Year: 2015
Adherence to sublingual immunotherapy in patients allergic to mites Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E Year: 2011
The co-morbidity of allergic hay fever, asthma and related disorders in randomly selected patients with respiratory allergic diseases Source: Annual Congress 2005 - Environmental factors, allergy and asthma Year: 2005
Grass pollen allergen induces asthma symptoms in a murine model of acute allergic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 587s Year: 2005
Association between Th2 biomarker levels and efficacy of house dust mite sublingual allergy immunotherapy in adults with allergic asthma Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021